JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Impact of opioids and mu-opioid receptors on oncologic metastasis

  • 0Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China.
American Journal of Cancer Research +

|

October 17, 2024

|

October 17, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Opioids, commonly used for cancer pain, may unexpectedly promote cancer metastasis. Further research is needed to understand the role of mu-opioid receptors (MORs) in cancer progression and patient outcomes.

Area Of Science

  • Oncology
  • Pharmacology
  • Cancer Metastasis Research

Background

  • Opioids are primary analgesics for cancer pain.
  • Emerging evidence suggests opioids may influence cancer progression.
  • Mu-opioid receptors (MORs) are key mediators of opioid action.

Purpose Of The Study

  • To review the impact of opioids and MORs on oncologic metastasis.
  • To explore the link between opioid use and cancer progression.
  • To identify research gaps regarding opioids, MORs, and metastasis.

Main Methods

  • Literature review of studies on opioids, MORs, and cancer metastasis.
  • Analysis of preclinical and clinical data.
  • Synthesis of findings on tumor progression, angiogenesis, EMT, CTCs, and TME.

Main Results

  • Opioids have been associated with facilitating tumor progression.
  • MORs are implicated in malignant transformation, proliferation, and angiogenesis.
  • Opioid use correlates with poor prognosis in some cancer patients.

Conclusions

  • Opioids and MORs play a complex role in cancer metastasis.
  • Further clinical trials are necessary to elucidate the precise relationship.
  • Understanding these interactions could inform future cancer treatment strategies.

Keywords:

Related Concept Videos

Opioid Receptors: Overview 01:22

555

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

Analgesia and Pain Management 01:25

540

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Morphine and Other Natural Cogeners 01:20

188

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Opioid Analgesics: Synthetic and Semisynthetic Opioids 01:15

237

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Mitogens and the Cell Cycle 02:38

6.4K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...